Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells
Abstract
We examined the effects of lansoprazole, a proton-pump inhibitor, on peripheral blood mononuclear cells in healthy subjects in comparison with ranitidine. Ten healthy volunteers were randomly divided into two groups and given either lansoprazole (30 mg daily for 2 days) or ranitidine (150 mg daily for 21 days). Peripheral blood was collected before and 7, 14, and 21 days after the start of treatment. Mononuclear cells were isolated by densitometric centrifugation and were examined for adhesion molecules (ICAM-1, VLA4, SLe(x)), membrane markers of the monocyte/macrophage series, and lymphocyte phenotypes. The number of cells expressing adhesion molecules, the number of monocytes/macrophages, and lymphocyte phenotypes were the same in Helicobacter pylori-positive and -negative subjects. The number of cells expressing ICAM-1 was significantly decreased seven days after the start of lansoprazole treatment, and this change persisted until day 14, while ranitidine had no effect. The number of monocytes (identified by Leu-M3 positivity) was decreased seven days after the start of treatment in both groups, but predominantly in the lansoprazole group. No other changes were observed on administration of either drug. These results suggest that short-term treatment with lansoprazole causes persistent inhibition of inflammatory responses irrespective of the presence of H. pylori infection. This effect may indicate a possible new mechanism of action of proton-pump inhibitors other than…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- The Prediction of the In Vitro Release Curves for PLGA-Based Drug Delivery Systems with Neural Networks
- Promising Ursolic Acid as a Novel Antituberculosis Agent: Current Progress and Challenges
- Proof of principle concept for the analysis and functional prediction of rare genetic variants in the CYP2C19 and CYP2D6 genes
- Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method
- The Effect of Concomitant Administration of Proton Pump Inhibitors on the Pharmacokinetics of CDK4/6 Inhibitors in Rats: Implications for the Evaluation of Hepatic and Transporter-Mediated Drug–Drug Interactions
- Mining the Metabolic Capacity of Clostridium sporogenes Aided by Machine Learning
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.